Mitchell L.Shiffman: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Hepatic lidocaine metabolism and liver histology in patients with chronic hepatitis and cirrhosis

Mitchell L. Shiffman, Velimir A. Luketic, Arun J. Sanyal, P. Frederick Duckworth, Preston P. Purdum III, Melissa J. Contos, A. Scott Mills, Leslie E. Edinboro, Alphonse Poklis

Journal:

Year:

1994

Language:

english

File:

PDF, 903 KB

english, 1994

2

Biliary bile acids in primary biliary cirrhosis: Effect of ursodeoxycholic acid

Burton Combes, Robert L. Carithers Jr., Willis C. Maddrey, Santiago Munoz, Guadalupe Garcia-Tsao, Gregory F. Bonner, James L. Boyer, Velimir A. Luketic, Mitchell L. Shiffman, Marion G. Peters, Heather

Journal:

Year:

1999

Language:

english

File:

PDF, 92 KB

english, 1999

3

Four-year follow-up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation

Robert A Fisher, James J Stone, Luke G Wolfe, Cheryl M Rodgers, Melodie L Anderson, Richard K Sterling, Mitchell L Shiffman, Velimer A Luketic, Melissa J Contos, A Scott Mills, Andrea Ferreira-Gonzale

Journal:

Clinical Transplantation

Year:

2004

Language:

english

File:

PDF, 141 KB

english, 2004

4

Fat transfer to the face

Shiffman, Melvin A, Kaminski, Mitchell V

Journal:

Facial Plastic Surgery Clinics of North America

Year:

2002

Language:

english

File:

PDF, 360 KB

english, 2002

5

A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis

Sanyal, Arun J., Mofrad, Pouneh S., Contos, Melissa J., Sargeant, Carol, Luketic, Velimir A., Sterling, Richard K., Stravitz, R. Todd, Shiffman, Mitchell L., Clore, John, Mills, Alan S.

Journal:

Clinical Gastroenterology and Hepatology

Year:

2004

Language:

english

File:

PDF, 183 KB

english, 2004

6

Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection

Pianko, Stephen, Flamm, Steven L., Shiffman, Mitchell L., Kumar, Sonal, Strasser, Simone I., Dore, Gregory J., McNally, John, Brainard, Diana M., Han, Lingling, Doehle, Brian, Mogalian, Erik, McHutchi

Journal:

Annals of Internal Medicine

Year:

2015

Language:

english

File:

PDF, 167 KB

english, 2015

7

Prophylaxis against Gallstone Formation with Ursodeoxycholic Acid in Patients Participating in a Very-Low-Calorie Diet Program

Shiffman, Mitchell L.

Journal:

Annals of Internal Medicine

Year:

1995

Language:

english

File:

PDF, 1.46 MB

english, 1995

8

The Conundrum of Cryptogenic Cirrhosis: Adverse Outcomes without Treatment Options

Younossi, Zobair, Stepanova, Maria, Sanyal, Arun J., Harrison, Stephen A., Ratziu, Vlad, Abdelmalek, Manal F., Diehl, Anna Mae, Caldwell, Stephen, Shiffman, Mitchell L., Schall, Raul Aguilar, McColgan

Journal:

Journal of Hepatology

Year:

2018

Language:

english

File:

PDF, 661 KB

english, 2018

9

The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC

Trauner, Michael, Gulamhusein, Aliya, Hameed, Bilal, Caldwell, Stephen, Shiffman, Mitchell L., Landis, Charles, Eksteen, Bertus, Agarwal, Kosh, Muir, Andrew, Rushbrook, Simon, Lu, Xiaomin, Xu, Jun, Ch

Journal:

Year:

2019

Language:

english

File:

PDF, 826 KB

english, 2019

10

The Natural History of Advanced Fibrosis due to Nonalcoholic Steatohepatitis: Data from the Simtuzumab Trials

Sanyal, Arun J., Harrison, Stephen A., Ratziu, Vlad, Abdelmalek, Manal F., Diehl, Anna Mae, Caldwell, Stephen, Shiffman, Mitchell L., Schall, Raul Aguilar, Jia, Catherine, McColgan, Bryan, Djedjos, C.

Journal:

Year:

2019

Language:

english

File:

PDF, 1.03 MB

english, 2019

11

Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: Results of a prospective controlled study

Arun J. Sanyal, Arthur M. Freedman, Mitchell L. Shiffman, Preston P. Purdum III, Velimir A. Luketic, Andrea K. Cheatham

Journal:

Year:

1994

Language:

english

File:

PDF, 947 KB

english, 1994

12

Quantitative liver testing with MEG-X: More optimism?

Jorg Ziebell, Thomas A. Shaw-Stiffel, Mitchell L. Shiffman

Journal:

Year:

1995

Language:

english

File:

PDF, 398 KB

english, 1995

13

The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: A conference sponsored by the national digestive diseases advisory board

Mitchell L. Shiffman, Lennox Jeffers, Jay H. Hoofnagle, Tommie Sue Tralka

Journal:

Year:

1995

Language:

english

File:

PDF, 939 KB

english, 1995

14

Retreatment of patients with chronic hepatitis C

Mitchell L. Shiffman

Journal:

Year:

2002

Language:

english

File:

PDF, 735 KB

english, 2002

15

Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy

Paul J. Pockros, Mitchell L. Shiffman, Eugene R. Schiff, Mark S. Sulkowski, Zobair Younossi, Douglas T. Dieterich, Teresa L. Wright, Samir H. Mody, K. Linda Tang, Betty L. Goon, Peter J. Bowers, Gerha

Journal:

Year:

2004

Language:

english

File:

PDF, 221 KB

english, 2004

16

Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C

Arun J. Sanyal, Colin Banas, Carol Sargeant, Velimir A. Luketic, Richard K. Sterling, Richard T. Stravitz, Mitchell L. Shiffman, Douglas Heuman, Adrian Coterrell, Robert A. Fisher, Melissa J. Contos,

Journal:

Year:

2006

Language:

english

File:

PDF, 164 KB

english, 2006

17

HCV RNA detection by TMA during the hepatitis C antiviral long-term treatment against cirrhosis (Halt-C) trial

Chihiro Morishima, Timothy R. Morgan, James E. Everhart, Elizabeth C. Wright, Mitchell L. Shiffman, Gregory T. Everson, Karen L. Lindsay, Anna S. F. Lok, Herbert L. Bonkovsky, Adrian M. Di Bisceglie,

Journal:

Year:

2006

Language:

english

File:

PDF, 199 KB

english, 2006

18

Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial

Gregory T. Everson, John C. Hoefs, Leonard B. Seeff, Herbert L. Bonkovsky, Deepa Naishadham, Mitchell L. Shiffman, Jeffrey A. Kahn, Anna S. F. Lok, Adrian M. Di Bisceglie, William M. Lee, Jules L. Die

Journal:

Year:

2006

Language:

english

File:

PDF, 352 KB

english, 2006

19

Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C

Paul J. Pockros, Eugene R. Schiff, Mitchell L. Shiffman, John G. McHutchison, Robert G. Gish, Nezam H. Afdhal, Manana Makhviladze, Mira Huyghe, David Hecht, Tilman Oltersdorf, David A. Shapiro

Journal:

Year:

2007

Language:

english

File:

PDF, 821 KB

english, 2007

20

A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C

Hongjin Huang, Mitchell L. Shiffman, Scott Friedman, Ramasubbu Venkatesh, Natalie Bzowej, Olivia T. Abar, Charles M. Rowland, Joseph J. Catanese, Diane U. Leong, John J. Sninsky, Thomas J. Layden, Ter

Journal:

Year:

2007

Language:

english

File:

PDF, 443 KB

english, 2007

21

Treatment of chronic hepatitis C virus genotype 1 with peginterferon, ribavirin, and epoetin alpha

Mitchell L. Shiffman, Jennifer Salvatore, Sarah Hubbard, Angie Price, Richard K. Sterling, R. Todd Stravitz, Velimir A. Luketic, Arun J. Sanyal

Journal:

Year:

2007

Language:

english

File:

PDF, 314 KB

english, 2007

22

Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virus

John G. McHutchison, Bruce R. Bacon, Stuart C. Gordon, Eric Lawitz, Mitchell Shiffman, Nezam H. Afdhal, Ira M. Jacobson, Andrew Muir, Mohammed Al-Adhami, Mary L. Morris, Julie A. Lekstrom-Himes, Susan

Journal:

Year:

2007

Language:

english

File:

PDF, 397 KB

english, 2007

23

The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome

Onpan Cheung, Ashwani Kapoor, Puneet Puri, Sakita Sistrun, Velimir A. Luketic, Carol C. Sargeant, Melissa J. Contos, Mitchell L. Shiffman, Richard T. Stravitz, Richard K. Sterling, Arun J. Sanyal

Journal:

Year:

2007

Language:

english

File:

PDF, 211 KB

english, 2007

24

Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial

Leonard B. Seeff, Teresa M. Curto, Gyongyi Szabo, Gregory T. Everson, Herbert L. Bonkovsky, Jules L. Dienstag, Mitchell L. Shiffman, Karen L. Lindsay, Anna S. F. Lok, Adrian M. Di Bisceglie, William M

Journal:

Year:

2008

Language:

english

File:

PDF, 239 KB

english, 2008

25

Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection

Richard K. Sterling, Melissa J. Contos, Paula G. Smith, R. Todd Stravitz, Velimir A. Luketic, Michael Fuchs, Mitchell L. Shiffman, Arun J. Sanyal

Journal:

Year:

2008

Language:

english

File:

PDF, 188 KB

english, 2008

26

R1626 plus peginterferon Alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin

Paul J. Pockros, David Nelson, Eliot Godofsky, Maribel Rodriguez-Torres, Gregory T. Everson, Michael W. Fried, Reem Ghalib, Stephen Harrison, Lisa Nyberg, Mitchell L. Shiffman, Isabel Najera, Anna Cha

Journal:

Year:

2008

Language:

english

File:

PDF, 586 KB

english, 2008

27

Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction–negative samples obtained after treatment of chronic hepatitis C

Chihiro Morishima, Timothy R. Morgan, James E. Everhart, Elizabeth C. Wright, Minjun C. Apodaca, David R. Gretch, Mitchell L. Shiffman, Gregory T. Everson, Karen L. Lindsay, William M. Lee, Anna S. F.

Journal:

Year:

2008

Language:

english

File:

PDF, 131 KB

english, 2008

28

High relapse rate seen at week 72 for patients treated with R1626 combination therapy

Paul Pockros, David Nelson, Eliot Godofsky, Maribel Rodriguez-Torres, Gregory T. Everson, Michael W. Fried, Reem Ghalib, Stephen Harrison, Lisa Nyberg, Mitchell L. Shiffman, Anna Chan, George Hill

Journal:

Year:

2008

Language:

english

File:

PDF, 65 KB

english, 2008

29

Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results

Bruce R. Bacon, Mitchell L. Shiffman, Flavia Mendes, Reem Ghalib, Tarek Hassanein, Giuseppe Morelli, Shobha Joshi, Kenneth Rothstein, Paul Kwo, Norman Gitlin

Journal:

Year:

2009

Language:

english

File:

PDF, 244 KB

english, 2009

30

A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naïve patients with chronic hepatitis C: ViSER1 results

Yves Benhamou, Nezam H. Afdhal, David R. Nelson, Mitchell L. Shiffman, Deanine G. Halliman, Jamie Heise, Eric Chun, Paul J. Pockros

Journal:

Year:

2009

Language:

english

File:

PDF, 452 KB

english, 2009

31

Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C

Neal D. Freedman, James E. Everhart, Karen L. Lindsay, Marc G. Ghany, Teresa M. Curto, Mitchell L. Shiffman, William M. Lee, Anna S. Lok, Adrian M. Di Bisceglie, Herbert L. Bonkovsky, John C. Hoefs, J

Journal:

Year:

2009

Language:

english

File:

PDF, 231 KB

english, 2009

32

Fibrosis progression in chronic hepatitis C: Morphometric image analysis in the HALT-C trial

Zachary D. Goodman, Anne M. Stoddard, Herbert L. Bonkovsky, Robert J. Fontana, Marc G. Ghany, Timothy R. Morgan, Elizabeth C. Wright, Elizabeth M. Brunt, David E. Kleiner, Mitchell L. Shiffman, Gregor

Journal:

Year:

2009

Language:

english

File:

PDF, 1.01 MB

english, 2009

33

Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis

Savino Bruno, Mitchell L. Shiffman, Stuart K. Roberts, Edward J. Gane, Diethelm Messinger, Stephanos J. Hadziyannis, Patrick Marcellin

Journal:

Year:

2010

Language:

english

File:

PDF, 500 KB

english, 2010

34

Identifying hepatitis C virus genotype 2/3 patients who can receive a 16-week abbreviated course of peginterferon alfa-2a (40KD) plus ribavirin

Moises Diago, Mitchell L. Shiffman, Jean-Pierre Bronowicki, Stefan Zeuzem, Maribel Rodriguez-Torres, Stephen C. Pappas, Andreas Tietz, David R. Nelson

Journal:

Year:

2010

Language:

english

File:

PDF, 230 KB

english, 2010

35

Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection

Andrew J. Muir, Mitchell L. Shiffman, Atif Zaman, Boris Yoffe, Andrew de la Torre, Steven Flamm, Stuart C. Gordon, Paul Marotta, John M. Vierling, Juan Carlos Lopez-Talavera, Kelly Byrnes-Blake, David

Journal:

Year:

2010

Language:

english

File:

PDF, 678 KB

english, 2010

36

Outcome of sustained virological responders with histologically advanced chronic hepatitis C

Timothy R. Morgan, Marc G. Ghany, Hae-Young Kim, Kristin K. Snow, Mitchell L. Shiffman, Jennifer L. De Santo, William M. Lee, Adrian M. Di Bisceglie, Herbert L. Bonkovsky, Jules L. Dienstag, Chihiro M

Journal:

Year:

2010

Language:

english

File:

PDF, 583 KB

english, 2010

37

Virologic response rates of weight-based taribavirin versus ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C

Fred Poordad, Eric Lawitz, Mitchell L. Shiffman, Tarek Hassanein, Andrew J. Muir, Bruce R. Bacon, Jamie Heise, Deanine Halliman, Eric Chun, Janet Hammond

Journal:

Year:

2010

Language:

english

File:

PDF, 265 KB

english, 2010

38

Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon

Adrian M. Di Bisceglie, Anne M. Stoddard, Jules L. Dienstag, Mitchell L. Shiffman, Leonard B. Seeff, Herbert L. Bonkovsky, Chihiro Morishima, Elizabeth C. Wright, Kristin K. Snow, William M. Lee, Robe

Journal:

Year:

2011

Language:

english

File:

PDF, 407 KB

english, 2011

39

Racial differences in hepatitis C treatment eligibility

Michael T. Melia, Andrew J. Muir, Jonathan McCone, Mitchell L. Shiffman, John W. King, Steven K. Herrine, Greg W. Galler, Joseph R. Bloomer, Frederick A. Nunes, Kimberly A. Brown, Kevin D. Mullen, Nat

Journal:

Year:

2011

Language:

english

File:

PDF, 258 KB

english, 2011

40

A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis C

Stefan Zeuzem, Uwe Hopf, Vicente Carreno, Moisés Diago, Mitchell Shiffman, Stefan Grüne, Francis J. Dudley, Ashok Rakhit, Karen Rittweger, Sing Hiem Yap, Raymond S. Koff, Howard C. Thomas

Journal:

Year:

1999

Language:

english

File:

PDF, 114 KB

english, 1999

41

Ethnicity and cytokine production gauge response of patients with hepatitis C to interferon-α therapy

Pam Kimball, R.K. Elswick, Mitchell Shiffman

Journal:

Journal of Medical Virology

Year:

2001

Language:

english

File:

PDF, 110 KB

english, 2001

42

Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation

R. Todd Stravitz, Mitchell L. Shiffman, Arun J. Sanyal, Velimir A. Luketic, Richard K. Sterling, Douglas M. Heuman, April Ashworth, A. Scott Mills, Melissa Contos, Adrian H. Cotterell, Daniel Maluf, M

Journal:

Liver Transplantation

Year:

2004

Language:

english

File:

PDF, 938 KB

english, 2004

43

Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation

Mitchell L. Shiffman, R. Todd Stravitz, Melissa J. Contos, A. Scott Mills, Richard K. Sterling, Velimir A. Luketic, Arun J. Sanyal, Adrian Cotterell, Daniel Maluf, Marc P. Posner, Robert A. Fisher

Journal:

Liver Transplantation

Year:

2004

Language:

english

File:

PDF, 112 KB

english, 2004

44

Outcomes in hepatitis C virus–infected recipients of living donor vs. deceased donor liver transplantation

Norah A. Terrault, Mitchell L. Shiffman, Anna S.F. Lok, Sammy Saab, Lan Tong, Robert S. Brown Jr., Gregory T. Everson, K. Rajender Reddy, Jeffrey H. Fair, Laura M. Kulik, Timothy L. Pruett, Leonard B.

Journal:

Liver Transplantation

Year:

2007

Language:

english

File:

PDF, 166 KB

english, 2007

45

A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation

Nevin Yilmaz, Mitchell L. Shiffman, R. Todd Stravitz, Richard K. Sterling, Velimir A. Luketic, Arun J. Sanyal, A. Scott Mills, Melissa J. Contos, Adrian Coterell, Daniel Maluf, Marc P. Posner, Robert

Journal:

Liver Transplantation

Year:

2007

Language:

english

File:

PDF, 186 KB

english, 2007

46

Treating chronic hepatitis C virus after liver transplantation: Balancing the risks against the chance for success

Mitchell L. Shiffman

Journal:

Liver Transplantation

Year:

2007

Language:

english

File:

PDF, 72 KB

english, 2007

47

Role and support for hepatologists at liver transplant programs in the United States

Mitchell L. Shiffman, Don C. Rockey

Journal:

Liver Transplantation

Year:

2008

Language:

english

File:

PDF, 199 KB

english, 2008

48

Impact of the donor liver with steatosis in patients with hepatitis C virus: Not so FAst

Nevin Yilmaz, Mitchell L. Shiffman

Journal:

Liver Transplantation

Year:

2009

Language:

english

File:

PDF, 64 KB

english, 2009

49

Incidence of prolonged length of stay after orthotopic liver transplantation and its influence on outcomes

Jenny O. Smith, Mitchell L. Shiffman, Martha Behnke, R. Todd Stravitz, Velimir A. Luketic, Arun J. Sanyal, Doug M. Heuman, Robert A. Fisher, Adrian H. Cotterell, Daniel G. Maluf, Marc P. Posner, Richa

Journal:

Liver Transplantation

Year:

2009

Language:

english

File:

PDF, 180 KB

english, 2009

50

Treatment of fulminant hepatic failure with intravenous prostaglandin E1

Richard K. Sterling, Velimir A. Luketic, Arun J. Sanyal, Mitchell L. Shiffman

Journal:

Liver Transplantation

Year:

1998

Language:

english

File:

PDF, 93 KB

english, 1998